TIRZEP, aka Tirzepatide, is a dual GIP and GLP-1 receptor agonist originally developed for type 2 diabetes management. It has gained significant attention for its potent effects on weight loss, appetite regulation, and metabolic function. Unlike traditional GLP-1 agonists, Tirzepatide activates two incretin pathways, contributing to stronger glycaemic control and fat reduction. Athletes and bodybuilders also research it during recomposition or contest prep for its appetite-blunting and fat-shredding potential.

Benefits of Tirzepatide

• Powerful appetite suppression and satiety support
• Rapid and sustained weight and fat loss
• Improves insulin sensitivity and blood glucose control
• Enhances metabolic rate and energy utilization
• May support cardiovascular and liver health